Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual ...
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual ...
“Access to the PSPP program will advance our understanding and development of ART26.12,” commented Saoirse O’Sullivan, PhD, Vice President Translational Science at Artelo Biosciences. “We are most ...
Sciences, the Oxford-based leader in single-cell biology handling solutions announced today the publication of validation work related to the use of its isoPick™ Single-Cell Picking Platform for an ...
For fiscal 2024, the company now expects revenues of about $13.27 billion, representing a 23.2 percent year-over-year decrease, in the low-end of the ... is expected to result in annual cost ...
This article will be updated as more CoD seasons are released and new information is revealed by Activision and its development studios. Senior Staff Writer & Call of Duty lead. Professional ...